AdBio

Financial Services · Venture Capital
$48.1Mraised by its portfolio in 12 months
19open roles in its portfolio
23investments
1exit

Overview

AdBio partners (formerly Advent France Biotechnology) is a venture capital firm investing in early stage life sciences companies in Europe AdBio partners' unique strategy combines early-stage investments in promising startups and strong entrepreneurial support to enable and strengthen the company's growth.

Investor profile

Venture capital
Investments
23
9 of them startups
Hiring now
3
19 open roles
Rounds in 12 months
1
$48.1M raised
Exits
1
Focusshare of its companies
Health Care 71%Biotechnology 29%Education 14%Artificial Intelligence 14%
Where its companies are
Spain 9%France 9%Belgium 4%United States 4%Germany 4%
Stage of its companies
Series A 33%Series B 33%Pre-seed & seed 33%
Its companies, the freshest money firstAll 23 investments
SparingvisionVenture round $48.1M · this month astraveusSeed $17.8M · 3 yr ago · 3 roles DioGenXSeries A $30M · 3 yr ago Tenpoint Therapeutics12 roles Agomab Therapeutics4 roles Arthex Biotech Orikine Evlabio mlcom Augustine Therapeutics Cookiedatabase.org
19 open roles at 3 of its companies
Hiring fastestroles opened in 30 days
Agomab Therapeutics4 new roles in 30 days Tenpoint Therapeutics3 new roles in 30 days
Co-investorscompanies they hold together
Asabys Partners 3 shared Ysios Capital 2 shared Jeito Capital 2 shared V-Bio Ventures 2 shared Omnes Capital 2 shared
Similar investorstheir companies share markets and countries
Jeito Capital BioGeneration Ventures Novartis Venture Fund Sofinnova Investments SR One Nextech Invest RA Capital Management venBio Partners
Sources: its portfolio page, read Nov 3